PASITHEA THERAPEUTICS CORP. Asset at Fair Value, Changes in Fair Value Resulting from Changes in Assumptions
PASITHEA THERAPEUTICS CORP. (KTTA) reported Asset at Fair Value, Changes in Fair Value Resulting from Changes in Assumptions of $30.20 thousand for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-11.
Discontinued › Notes
us-gaap:AssetAtFairValueChangesInFairValueResultingFromChangesInAssumptions · last filed 2023-08-11
- PASITHEA THERAPEUTICS CORP. asset at fair value, changes in fair value resulting from changes in assumptions for the quarter ending 2023-06-30 was $30.20K.
| Period end | Asset at Fair Value, Changes in Fair Value Resulting from Changes in Assumptions 3 month | Asset at Fair Value, Changes in Fair Value Resulting from Changes in Assumptions 6 month |
|---|---|---|
| 2023-06-30 | $30.20K 10-Q · filed 2023-08-11 | $87.61K 10-Q · filed 2023-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |